Need help finding what you are looking for?
Contact Us
PUBLISHER: KBV Research | PRODUCT CODE: 1173226
PUBLISHER: KBV Research | PRODUCT CODE: 1173226
LAMEA AI In Cancer Diagnostics Market Size, Share & Industry Trends Analysis Report By End-user, By Component, By Cancer Type, By Country and Growth Forecast, 2022 - 2028
PUBLISHED:
PAGES: 86 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
The Latin America, Middle East and Africa AI In Cancer Diagnostics Market would witness market growth of 32.5% CAGR during the forecast period (2022-2028).
In the detection of cancer, the Imaging process is used for developing precise photos of the body's organs and structure. The imaging is also used to identify the abnormalities, condition, and location of the tumor. It can be utilized in various procedures such as biopsies and surgeries. Reflecting imaging, emission imaging, and transmission imaging are the three various types of imaging utilized in diagnosing cancer. X-rays, CT scans, and fluoroscopy images are sent from radiological exams.
Additionally, many other researchers can quickly determine the subtype of cancer by uploading methylation profiles into research which also delivers a confidence level that indicates the probability that the result is precise. As per the German neuropathologist, Andreas von Deimling, moreover about 1000 such reports are submitted each year.
As the United Arab Emirates (UAE) is becoming one of the fastest-growing economies the number of patients related to chronic diseases like cancer is also increasing. Even after the initial detection efforts and screening the number of registered cases and fatalities in UAE has increased significantly, this can be attributed to the fact that the coverage of people is less than the targeted population.
The Brazil market dominated the LAMEA AI In Cancer Diagnostics Market by Country in 2021; thereby, achieving a market value of $8.5 million by 2028. The Argentina market is showcasing a CAGR of 33.2% during (2022 - 2028). Additionally, The UAE market would register a CAGR of 32.1% during (2022 - 2028).
Based on End-user, the market is segmented into Hospital, Surgical Centers & Medical Institutes and Others. Based on Component, the market is segmented into Software Solutions, Hardware and Services. Based on Cancer Type, the market is segmented into Breast Cancer, Lung Cancer, Brain Tumor, Skin Cancer & Cervical Cancer, Prostate & Colorectal Cancer and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Microsoft Corporation, Flatiron Health, Paige AI, Inc., PathAI, Inc., Therapixel, Tempus, Inc., SkinVision BV, Cancer Center Sp. z o.o., Medial EarlySign and Kheiron Medical Technologies Limited.
Scope of the Study
Market Segments covered in the Report:
By End-user
- Hospital
- Surgical Centers & Medical Institutes
- Others
By Component
- Software Solutions
- Hardware
- Services
By Cancer Type
- Breast Cancer
- Lung Cancer
- Brain Tumor
- Skin Cancer & Cervical Cancer
- Prostate & Colorectal Cancer
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Companies Profiled
- Microsoft Corporation
- Flatiron Health
- Paige AI, Inc.
- PathAI, Inc.
- Therapixel
- Tempus, Inc.
- SkinVision BV
- Cancer Center Sp. z o.o.
- Medial EarlySign
- Kheiron Medical Technologies Limited
Unique Offerings from KBV Research
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 LAMEA AI In Cancer Diagnostics Market, by End-user
- 1.4.2 LAMEA AI In Cancer Diagnostics Market, by Component
- 1.4.3 LAMEA AI In Cancer Diagnostics Market, by Cancer Type
- 1.4.4 LAMEA AI In Cancer Diagnostics Market, by Country
- 1.5 Methodology for the research
Chapter 2. Market Overview
- 2.1 Introduction
- 2.1.1 Overview
- 2.1.1.1 Market Composition & Scenarios
- 2.1.1 Overview
- 2.2 Key Factors Impacting the Market
- 2.2.1 Market Drivers
- 2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
- 3.1 KBV Cardinal Matrix
- 3.2 Recent Industry Wide Strategic Developments
- 3.2.1 Partnerships, Collaborations and Agreements
- 3.2.2 Product Launches and Product Expansions
- 3.2.3 Acquisition and Mergers
- 3.3 Top Winning Strategies
- 3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
- 3.3.2 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
Chapter 4. LAMEA AI In Cancer Diagnostics Market by End-user
- 4.1 LAMEA Hospital Market by Country
- 4.2 LAMEA Surgical Centers & Medical Institutes Market by Country
- 4.3 LAMEA Others Market by Country
Chapter 5. LAMEA AI In Cancer Diagnostics Market by Component
- 5.1 LAMEA Software Solutions Market by Country
- 5.2 LAMEA Hardware Market by Country
- 5.3 LAMEA Services Market by Country
Chapter 6. LAMEA AI In Cancer Diagnostics Market by Cancer Type
- 6.1 LAMEA Breast Cancer Market by Country
- 6.2 LAMEA Lung Cancer Market by Country
- 6.3 LAMEA Brain Tumor Market by Country
- 6.4 LAMEA Skin Cancer & Cervical Cancer Market by Country
- 6.5 LAMEA Prostate & Colorectal Cancer Market by Country
- 6.6 LAMEA Others Market by Country
Chapter 7. LAMEA AI In Cancer Diagnostics Market by Country
- 7.1 Brazil AI In Cancer Diagnostics Market
- 7.1.1 Brazil AI In Cancer Diagnostics Market by End-user
- 7.1.2 Brazil AI In Cancer Diagnostics Market by Component
- 7.1.3 Brazil AI In Cancer Diagnostics Market by Cancer Type
- 7.2 Argentina AI In Cancer Diagnostics Market
- 7.2.1 Argentina AI In Cancer Diagnostics Market by End-user
- 7.2.2 Argentina AI In Cancer Diagnostics Market by Component
- 7.2.3 Argentina AI In Cancer Diagnostics Market by Cancer Type
- 7.3 UAE AI In Cancer Diagnostics Market
- 7.3.1 UAE AI In Cancer Diagnostics Market by End-user
- 7.3.2 UAE AI In Cancer Diagnostics Market by Component
- 7.3.3 UAE AI In Cancer Diagnostics Market by Cancer Type
- 7.4 Saudi Arabia AI In Cancer Diagnostics Market
- 7.4.1 Saudi Arabia AI In Cancer Diagnostics Market by End-user
- 7.4.2 Saudi Arabia AI In Cancer Diagnostics Market by Component
- 7.4.3 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type
- 7.5 South Africa AI In Cancer Diagnostics Market
- 7.5.1 South Africa AI In Cancer Diagnostics Market by End-user
- 7.5.2 South Africa AI In Cancer Diagnostics Market by Component
- 7.5.3 South Africa AI In Cancer Diagnostics Market by Cancer Type
- 7.6 Nigeria AI In Cancer Diagnostics Market
- 7.6.1 Nigeria AI In Cancer Diagnostics Market by End-user
- 7.6.2 Nigeria AI In Cancer Diagnostics Market by Component
- 7.6.3 Nigeria AI In Cancer Diagnostics Market by Cancer Type
- 7.7 Rest of LAMEA AI In Cancer Diagnostics Market
- 7.7.1 Rest of LAMEA AI In Cancer Diagnostics Market by End-user
- 7.7.2 Rest of LAMEA AI In Cancer Diagnostics Market by Component
- 7.7.3 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type
Chapter 8. Company Profiles
- 8.1 Microsoft Corporation
- 8.1.1 Company Overview
- 8.1.2 Financial Analysis
- 8.1.3 Segmental and Regional Analysis
- 8.1.4 Research & Development Expenses
- 8.1.5 SWOT Analysis
- 8.2 Flatiron Health (F. Hoffmann-La Roche Ltd.)
- 8.2.1 Company Overview
- 8.2.2 Financial Analysis
- 8.2.3 Segmental and Regional Analysis
- 8.2.4 Research & Development Expense
- 8.2.5 Recent strategies and developments:
- 8.2.5.1 Partnerships, Collaborations, and Agreements:
- 8.3 Paige AI, Inc.
- 8.3.1 Company Overview
- 8.3.2 Recent strategies and developments:
- 8.3.2.1 Partnerships, Collaborations, and Agreements:
- 8.3.2.2 Product Launches and Product Expansions:
- 8.4 PathAI, Inc.
- 8.4.1 Company Overview
- 8.4.2 Recent strategies and developments:
- 8.4.2.1 Partnerships, Collaborations, and Agreements:
- 8.4.2.2 Acquisition and Mergers:
- 8.5 Therapixel
- 8.5.1 Company Overview
- 8.5.2 Recent strategies and developments:
- 8.5.2.1 Product Launches and Product Expansions:
- 8.6 Tempus, Inc.
- 8.6.1 Company Overview
- 8.6.2 Recent strategies and developments:
- 8.6.2.1 Partnerships, Collaborations, and Agreements:
- 8.7 SkinVision BV
- 8.7.1 Company Overview
- 8.8 Cancer Center Sp. z o.o.
- 8.8.1 Company Overview
- 8.9 Medial EarlySign
- 8.9.1 Company Overview
- 8.10. Kheiron Medical Technologies Limited
- 8.10.1 Company Overview
- 8.10.2 Recent strategies and developments:
- 8.10.2.1 Partnerships, Collaborations, and Agreements:
LIST OF TABLES
- TABLE 1 LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 2 LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 3 Partnerships, Collaborations and Agreements- AI In Cancer Diagnostics Market
- TABLE 4 Product Launches And Product Expansions- AI In Cancer Diagnostics Market
- TABLE 5 Acquisition and Mergers- AI In Cancer Diagnostics Market
- TABLE 6 LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 7 LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 8 LAMEA Hospital Market by Country, 2018 - 2021, USD Thousands
- TABLE 9 LAMEA Hospital Market by Country, 2022 - 2028, USD Thousands
- TABLE 10 LAMEA Surgical Centers & Medical Institutes Market by Country, 2018 - 2021, USD Thousands
- TABLE 11 LAMEA Surgical Centers & Medical Institutes Market by Country, 2022 - 2028, USD Thousands
- TABLE 12 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 13 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 14 LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 15 LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 16 LAMEA Software Solutions Market by Country, 2018 - 2021, USD Thousands
- TABLE 17 LAMEA Software Solutions Market by Country, 2022 - 2028, USD Thousands
- TABLE 18 LAMEA Hardware Market by Country, 2018 - 2021, USD Thousands
- TABLE 19 LAMEA Hardware Market by Country, 2022 - 2028, USD Thousands
- TABLE 20 LAMEA Services Market by Country, 2018 - 2021, USD Thousands
- TABLE 21 LAMEA Services Market by Country, 2022 - 2028, USD Thousands
- TABLE 22 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 23 LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 24 LAMEA Breast Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 25 LAMEA Breast Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 26 LAMEA Lung Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 27 LAMEA Lung Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 28 LAMEA Brain Tumor Market by Country, 2018 - 2021, USD Thousands
- TABLE 29 LAMEA Brain Tumor Market by Country, 2022 - 2028, USD Thousands
- TABLE 30 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 31 LAMEA Skin Cancer & Cervical Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 32 LAMEA Prostate & Colorectal Cancer Market by Country, 2018 - 2021, USD Thousands
- TABLE 33 LAMEA Prostate & Colorectal Cancer Market by Country, 2022 - 2028, USD Thousands
- TABLE 34 LAMEA Others Market by Country, 2018 - 2021, USD Thousands
- TABLE 35 LAMEA Others Market by Country, 2022 - 2028, USD Thousands
- TABLE 36 LAMEA AI In Cancer Diagnostics Market by Country, 2018 - 2021, USD Thousands
- TABLE 37 LAMEA AI In Cancer Diagnostics Market by Country, 2022 - 2028, USD Thousands
- TABLE 38 Brazil AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 39 Brazil AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 40 Brazil AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 41 Brazil AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 42 Brazil AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 43 Brazil AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 44 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 45 Brazil AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 46 Argentina AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 47 Argentina AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 48 Argentina AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 49 Argentina AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 50 Argentina AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 51 Argentina AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 52 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 53 Argentina AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 54 UAE AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 55 UAE AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 56 UAE AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 57 UAE AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 58 UAE AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 59 UAE AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 60 UAE AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 61 UAE AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 62 Saudi Arabia AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 63 Saudi Arabia AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 64 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 65 Saudi Arabia AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 66 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 67 Saudi Arabia AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 68 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 69 Saudi Arabia AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 70 South Africa AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 71 South Africa AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 72 South Africa AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 73 South Africa AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 74 South Africa AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 75 South Africa AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 76 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 77 South Africa AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 78 Nigeria AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 79 Nigeria AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 80 Nigeria AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 81 Nigeria AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 82 Nigeria AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 83 Nigeria AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 84 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 85 Nigeria AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 86 Rest of LAMEA AI In Cancer Diagnostics Market, 2018 - 2021, USD Thousands
- TABLE 87 Rest of LAMEA AI In Cancer Diagnostics Market, 2022 - 2028, USD Thousands
- TABLE 88 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2018 - 2021, USD Thousands
- TABLE 89 Rest of LAMEA AI In Cancer Diagnostics Market by End-user, 2022 - 2028, USD Thousands
- TABLE 90 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2018 - 2021, USD Thousands
- TABLE 91 Rest of LAMEA AI In Cancer Diagnostics Market by Component, 2022 - 2028, USD Thousands
- TABLE 92 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2018 - 2021, USD Thousands
- TABLE 93 Rest of LAMEA AI In Cancer Diagnostics Market by Cancer Type, 2022 - 2028, USD Thousands
- TABLE 94 key information - Microsoft Corporation
- TABLE 95 Key Information - Flatiron Health
- TABLE 96 Key Information -Paige AI, Inc.
- TABLE 97 Key Information - PathAI, Inc.
- TABLE 98 Key Information -Therapixel
- TABLE 99 Key Information - Tempus, Inc.
- TABLE 100 Key Information - SkinVision BV
- TABLE 101 Key Information - Cancer Center Sp. z o.o.
- TABLE 102 Key Information - Medial EarlySign
- TABLE 103 Key Information - Kheiron Medical Technologies Limited
List of Figures
- FIG 1 Methodology for the research
- FIG 2 KBV Cardinal Matrix
- FIG 3 Key Leading Strategies: Percentage Distribution (2018-2022)
- FIG 4 Key Strategic Move: (Partnerships, Collaborations and Agreements: 2019, Dec - 2022, Nov) Leading Players
- FIG 5 SWOT Analysis: Microsoft Corporation
- FIG 6 Recent strategies and developments: Paige AI, Inc.
- FIG 7 Recent strategies and developments: PathAI, Inc.
Have a question?
SELECT AN OPTION
Have a question?
Questions? Please give us a call or visit the contact form.